Back

Bidirectional interaction between implantable cardioverter-defibrillator therapy and mental disorders: nationwide cohort study

31 March 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Device therapy (2) Clinical EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Juwon Kim

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Subcutaneous implantable cardioverter defibrillator in pediatric and young adults: an analysis from the European SIDECAR Registry
Doctor M. Silvetti (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Deprivation and device therapy: understanding the impact of socioeconomic status on ICD therapy outcomes
Mr C. Monkhouse (London, GB)
Abstract Slides Video
Presentation thumbnail
Predictors of syncope recurrence in reflex syncope patients with dual-chamber pacemakers with anti-reflex functionality
Doctor T. Vo (Ho Chi Minh, VN)
Abstract Slides Video
Presentation thumbnail
Implantable cardioverter defibrillator resistant mortality in ischemic and dilated cardiomyopathy across therapeutic eras: a single, tertiary center experience
Doctor M. Blondeel (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Defibrillation testing at implant of subcutaneous implantable cardioverter defibrillator: weighting propensity score analysis and results from nationwide HONEST cohort
Doctor F. kerkouri (Brest, FR)
Abstract Slides

Access the full session

Session thumbnail
Device therapy (2)

The Event

Event poster

EHRA 2025

31 March 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Quality of life and psychological well-being among heart failure patients living with an implantable cardioverter-defibrillator
thumbnail
Congress Presentation
Patients with ICD: the psychological considerations you should be aware of
thumbnail
Congress Presentation
Quality of life and psychological distress in patients with implantable cardioverter-defibrillators: the PSY-ICD study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources